Equator Therapeutics, Inc.
Publicly observedSaint Louis, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Saint Louis | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Equator Therapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | ECUUHHN4LUB8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Partial Agonism of Mitochondrial Thermogenesis for the Safe Stimulation of Energy Expenditure
USD 422,785.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2021Publicly observed
NIH SBIR/STTR award: New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders
USD 1,571,137.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.